Genmab A/S (CPH: GMAB)
1,873.50
-4.00 (-0.21%)
Aug 30, 2024, 4:59 PM CET
Genmab Revenue
Genmab had revenue of 5.40B DKK in the quarter ending June 30, 2024, with 29.58% growth. This brings the company's revenue in the last twelve months to 19.02B, up 17.19% year-over-year. In the year 2023, Genmab had annual revenue of 16.47B with 13.57% growth.
Revenue (ttm)
19.02B
Revenue Growth
+17.19%
P/S Ratio
6.41
Revenue / Employee
7.53M
Employees
2,204
Market Cap
118.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.47B | 1.97B | 13.57% |
Dec 31, 2022 | 14.51B | 6.09B | 72.33% |
Dec 31, 2021 | 8.42B | -1.69B | -16.75% |
Dec 31, 2020 | 10.11B | 4.75B | 88.43% |
Dec 31, 2019 | 5.37B | 2.34B | 77.39% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk A/S | 258.00B |
Coloplast A/S | 26.30B |
Demant A/S | 22.84B |
Zealand Pharma A/S | 367.97M |
H. Lundbeck A/S | 20.67B |
H. Lundbeck A/S | 20.67B |
ALK-Abelló A/S | 5.18B |
Ambu A/S | 5.08B |
Genmab News
- 4 days ago - Evaluating Regeneron Pharmaceuticals Against Peers In Biotechnology Industry - Benzinga
- 5 days ago - Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 8 days ago - Genmab: Strong H1 2024 Performance, Partner BioNTech Gives Up On Acasunlimab - Seeking Alpha
- 12 days ago - AbbVie, Genmab receive European approval for Tepkinly in follicular lymphoma - Seeking Alpha
- 12 days ago - TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma - Business Wire
- 18 days ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire
- 18 days ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 19 days ago - Genmab A/S 2024 Q2 - Results - Earnings Call Presentation - Seeking Alpha